A detailed history of Parallel Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Parallel Advisors, LLC holds 23,649 shares of LLY stock, worth $18.8 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
23,649
Previous 24,273 2.57%
Holding current value
$18.8 Million
Previous $22 Million 4.66%
% of portfolio
0.5%
Previous 0.57%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $481,815 - $599,052
-624 Reduced 2.57%
23,649 $21 Million
Q2 2024

Aug 08, 2024

BUY
$724.87 - $909.04 $382,006 - $479,064
527 Added 2.22%
24,273 $22 Million
Q1 2024

May 06, 2024

BUY
$592.2 - $792.28 $343,476 - $459,522
580 Added 2.5%
23,746 $18.5 Million
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $55,670 - $65,627
106 Added 0.46%
23,166 $13.5 Million
Q3 2023

May 20, 2024

BUY
$434.7 - $599.3 $144,755 - $199,566
333 Added 1.47%
23,060 $12.4 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $144,755 - $199,566
333 Added 1.47%
23,060 $12.4 Million
Q2 2023

May 20, 2024

BUY
$350.74 - $468.98 $250,428 - $334,851
714 Added 3.24%
22,727 $10.7 Million
Q2 2023

Aug 04, 2023

BUY
$350.74 - $468.98 $250,428 - $334,851
714 Added 3.24%
22,727 $10.7 Million
Q1 2023

May 20, 2024

SELL
$310.63 - $364.82 $538,321 - $632,233
-1,733 Reduced 7.3%
22,013 $7.56 Million
Q1 2023

Apr 25, 2023

BUY
$310.63 - $364.82 $510,675 - $599,764
1,644 Added 8.07%
22,013 $7.56 Million
Q4 2022

Feb 03, 2023

BUY
$321.55 - $374.67 $179,746 - $209,440
559 Added 2.82%
20,369 $7.45 Million
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $126,300 - $143,932
426 Added 2.2%
19,810 $6.41 Million
Q2 2022

Aug 01, 2022

BUY
$278.73 - $327.27 $57,418 - $67,417
206 Added 1.07%
19,384 $6.29 Million
Q1 2022

Apr 28, 2022

BUY
$234.69 - $291.66 $834,557 - $1.04 Million
3,556 Added 22.76%
19,178 $5.56 Million
Q4 2021

Jan 20, 2022

BUY
$224.85 - $279.04 $146,827 - $182,213
653 Added 4.36%
15,622 $4.32 Million
Q3 2021

Nov 02, 2021

SELL
$221.6 - $272.71 $427,688 - $526,330
-1,930 Reduced 11.42%
14,969 $3.46 Million
Q2 2021

Aug 06, 2021

BUY
$180.55 - $233.54 $97,316 - $125,878
539 Added 3.29%
16,899 $3.88 Million
Q1 2021

Apr 23, 2021

BUY
$164.32 - $212.72 $502,161 - $650,072
3,056 Added 22.97%
16,360 $3.06 Million
Q4 2020

Feb 02, 2021

SELL
$130.46 - $172.63 $287,272 - $380,131
-2,202 Reduced 14.2%
13,304 $2.25 Million
Q3 2020

Oct 27, 2020

BUY
$146.22 - $169.13 $15,937 - $18,435
109 Added 0.71%
15,506 $2.3 Million
Q2 2020

Jul 16, 2020

SELL
$136.42 - $164.18 $328,772 - $395,673
-2,410 Reduced 13.53%
15,397 $2.53 Million
Q1 2020

Apr 27, 2020

SELL
$119.05 - $147.35 $470,128 - $581,885
-3,949 Reduced 18.15%
17,807 $2.47 Million
Q4 2019

Jan 30, 2020

BUY
$106.92 - $132.43 $168,505 - $208,709
1,576 Added 7.81%
21,756 $2.86 Million
Q3 2019

Nov 01, 2019

SELL
$106.79 - $116.16 $61,297 - $66,675
-574 Reduced 2.77%
20,180 $2.26 Million
Q2 2019

Aug 05, 2019

SELL
$110.79 - $129.32 $160,091 - $186,867
-1,445 Reduced 6.51%
20,754 $2.3 Million
Q1 2019

May 01, 2019

SELL
$111.31 - $131.02 $173,977 - $204,784
-1,563 Reduced 6.58%
22,199 $2.88 Million
Q4 2018

Feb 05, 2019

SELL
$105.9 - $118.64 $26,263 - $29,422
-248 Reduced 1.03%
23,762 $2.75 Million
Q3 2018

Nov 01, 2018

BUY
$85.86 - $107.31 $290,550 - $363,137
3,384 Added 16.41%
24,010 $2.58 Million
Q2 2018

Jul 30, 2018

SELL
$75.7 - $86.88 $2,422 - $2,780
-32 Reduced 0.15%
20,626 $1.76 Million
Q1 2018

May 08, 2018

BUY
$74.21 - $87.6 $6,307 - $7,445
85 Added 0.41%
20,658 $1.6 Million
Q4 2017

Feb 13, 2018

SELL
$81.94 - $87.89 $3,113 - $3,339
-38 Reduced 0.18%
20,573 $1.74 Million
Q3 2017

Nov 15, 2017

BUY
$77.07 - $85.54 $1.59 Million - $1.76 Million
20,611 New
20,611 $1.71 Million
Q3 2017

Nov 14, 2017

SELL
$77.07 - $85.54 $1.61 Million - $1.79 Million
-20,888 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
20,888
20,888 $1.73 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $757B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.